TCS Biosciences Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 02172900 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

TCS BIOSCIENCES LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr K Langston

Mrs L J Preston

Mr J E Preston

Mrs E J Utley

Mr G A Williams

SECRETARY:

Mrs E J Utley

REGISTERED OFFICE:

Botolph Farm

Botolph Claydon

Buckingham

Buckinghamshire

MK18 2LR

REGISTERED NUMBER:

02172900 (England and Wales)

ACCOUNTANTS:

Martin and Company

Two Brewers House

50 North Street

Thame

Oxfordshire

OX9 3BH

FIXED ASSETS

Intangible assets

4

-

Tangible assets

5

707,476

650,599

707,476

650,599

CURRENT ASSETS

Stocks

726,909

1,107,441

Debtors

6

1,974,578

1,977,842

Investments

7

2,193,920

1,943,970

Cash at bank and in hand

5,939,220

5,838,570

10,834,627

10,867,823

CREDITORS

Amounts falling due within one year

8

814,648

1,349,415

NET CURRENT ASSETS

10,019,979

9,518,408

TOTAL ASSETS LESS CURRENT
LIABILITIES

10,727,455

10,169,007

PROVISIONS FOR LIABILITIES

78,572

60,659

NET ASSETS

10,648,883

10,108,348

CAPITAL AND RESERVES

Called up share capital

850

Capital redemption reserve

150

Retained earnings

10,647,883

10,107,348

10,648,883

10,108,348

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 August 2026 and were signed on its behalf by:

Mrs L J Preston - Director

1.	STATUTORY INFORMATION

TCS Biosciences Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Land and buildings

-

2% on cost

Plant and machinery etc

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 49 (2024 - 47 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 December 2024

and 30 November 2025

162,636

AMORTISATION

At 1 December 2024

and 30 November 2025

162,636

NET BOOK VALUE

At 30 November 2025

-

At 30 November 2024

-

5.	TANGIBLE FIXED ASSETS

Freehold

Property

Plant and

property

improvements

machinery

£

COST

At 1 December 2024

615,611

11,439

849,082

Additions

-

181,494

At 30 November 2025

615,611

11,439

1,030,576

DEPRECIATION

At 1 December 2024

207,647

11,439

700,834

Charge for year

14,775

-

67,077

At 30 November 2025

222,422

11,439

767,911

NET BOOK VALUE

At 30 November 2025

393,189

-

262,665

At 30 November 2024

407,964

-

148,248

Motor

Computer

vehicles

equipment

Totals

£

COST

At 1 December 2024

9,495

164,824

1,650,451

Additions

-

181,494

At 30 November 2025

9,495

164,824

1,831,945

DEPRECIATION

At 1 December 2024

7,936

71,996

999,852

Charge for year

1,559

41,206

124,617

At 30 November 2025

9,495

113,202

1,124,469

NET BOOK VALUE

At 30 November 2025

-

51,622

707,476

At 30 November 2024

1,559

92,828

650,599

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

Trade debtors

1,203,776

1,380,600

Amounts owed by group undertakings

602,257

476,267

Other debtors

168,545

120,975

1,974,578

1,977,842

7.	CURRENT ASSET INVESTMENTS

30.11.25

30.11.24

£

Listed investments

218,069

Unlisted investments

1,975,851

1,725,901

2,193,920

1,943,970

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

Bank loans and overdrafts

1,000

-

Trade creditors

262,013

719,078

Amounts owed to group undertakings

-

53,437

Taxation and social security

319,797

334,366

Other creditors

231,838

242,534

814,648

1,349,415